Filed pursuant to Rule 424(b)(3) Registration No. 333-43522 PRICING SUPPLEMENT NO. 9 to the Prospectus dated August 28, 2000 And the Prospectus Supplement dated September 6, 2000 Universal Corporation $400,000,000 Medium-Term Notes, Series B The notes being purchased have the following terms: PRINCIPAL AMOUNT: $8,500,000 STATED MATURITY: February 15, 2007 SPECIFIED CURRENCY: U.S. Dollars FIXED INTEREST RATE: 6.31% per annum ORIGINAL ISSUE DATE: February 19, 2002 CUSIP: 91345H AP 0 PRICE TO PUBLIC : $8,500,000, plus accrued interest from and including the Original Issue Date, if any; 100.00% per Note, plus accrued interest from and including the Original Issue Date, if any. AUTHORIZED DENOMINATIONS: Minimum denominations of $1,000 and integral multiples thereof. AGENT: First Union Securities, Inc. AGENT'S COMMISSION: $42,500 in the aggregate; 0.500% per Note NET PROCEEDS TO UNIVERSAL CORPORATION: $8,457,500 in the aggregate, plus accrued interest from and including the Original Issue Date, if any; 99.5 % per Note plus accrued interest from and including the Original Issue Date, if any. THIS OFFERING IS SUBJECT TO REOPENING AT A LATER TIME TO OFFER ADDITIONAL NOTES HAVING THE SAME TERMS AS THE NOTES BEING PURCHASED. DEPOSITARY: DTC FORM OF NOTE: - global registered book-entry form only: Yes - non-global form available: Upon certain events as described in the Prospectus - bearer note: No REDEMPTION AND REPAYMENT: Not redeemable or repayable prior to stated maturity FIXED RATE SECURITIES: - annual rate: 6.31% - interest payment dates: Each February 15 and August 15, commencing August 15, 2002 - regular record date: Close of business on each January 15 or July 15 (whether or not a Business Day) immediately preceding an interest payment date DEFEASANCE AND COVENANT DEFEASANCE: The Company may effect defeasance or covenant defeasance with respect to the notes upon meeting certain conditions as described in the Prospectus. OTHER INFORMATION: Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved these securities or passed upon the adequacy or accuracy of the Prospectus, the Prospectus Supplement or this Pricing Supplement. Any representation to the contrary is a criminal offense. Terms used and not defined herein but defined in the Prospectus Supplement and Prospectus are used herein as therein defined. UNIVERSAL CORPORATION Pricing Supplement dated February 13, 2002